Editorial Comment: Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control
(2020)
Journal Article
Coupland, C. A., Hill, T., Dening, T., Morriss, R., Moore, M., & Hippisley-Cox, J. (2020). Editorial Comment: Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control. International Braz J Urol, 46(2), 283-284. https://doi.org/10.1590/S1677-5538.IBJU.2020.02.10
Outputs (3)
Re: Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case Control Study (2019)
Journal Article
Wein, A. J., Coupland, C. A. C., Hill, T., Dening, T., Morriss, R., Moore, M., & Hippisley-Cox, J. (2019). Re: Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case Control Study. Journal of Urology, The, 202(6), 1103-1104. https://doi.org/10.1097/01.ju.0000585420.46543.d2
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study (2019)
Journal Article
Coupland, C. A., Hill, T., Dening, T., Morriss, R., Moore, M., & Hippisley-Cox, J. (2019). Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. JAMA Internal Medicine, 179(8), 1084-1093. https://doi.org/10.1001/jamainternmed.2019.0677IMPORTANCE Anticholinergic medicines have short-term cognitive adverse effects, but it
is uncertain whether long-term use of these drugs is associated with an increased risk of dementia.
OBJECTIVE To assess associations between anticholinergic dr... Read More about Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study.